Comparison of local infiltration and intra-peritoneal instillation of Ropivacaine effect on post-op pain, nausea, vomiting and analgesic requirement in laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230523058263N1

Enrollment

120

Registered

2023-05-31

Start date

2024-02-19

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystectomy.

Interventions

Intervention group: First group receive 20 cc 0.5% Ropivacaine intra-dermal in port's place. Second group as same but intra-peritoneally and third group (control) which received nothing..

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: people aged between 18-70 permission for surgery from cardiologist consultant no history of headache or migrane normal renal and hepatic function

Exclusion criteria

Exclusion criteria: history of previous surgery in abdomen concurrent pathology in billiary ducts conversion to open surgery severe hemodynamic changes during operation addiction people whom have cardiac diseases consist of heart failure, ischemic heart disease arrythmia

Design outcomes

Primary

Measure	Time frame
Pain-nausea-vomiting-analgesic requirement. Timepoint: recovery room-2-4-6-12-24 post-op hours. Method of measurement: by questionnaire and visual analogue scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaraji Soheyla

Karaj University of Medical Sciences

sohayla_f7_2012@yahoo.com+98 912 360 8876

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026